Skip to content

An App-based Instructional Platform to Improve Eye Drop Recall

Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06045390
Enrollment
20
Registered
2023-09-21
Start date
2024-09-01
Completion date
2025-06-01
Last updated
2025-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule. At one month, both groups will be assessed on their eye drop regimen recall.

Detailed description

Specific Aim: To investigate whether a language-concordant instructional application improves drop regimen recall in population of glaucoma patients at a 1-month follow-up period. App features 1. Pictorial representation of drops (color-coded) and schedule. 2. Quiz to assess understanding of the regimen. 3. Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop. 4. Graphical print-out of the regimen. Study design 1. Study design: Randomized study, two groups: (1) patients that use the app, and (2) patients that do not use the app. 2. Study population: Inclusion criteria: patients with primary open-angle glaucoma on at least 2 eye drops Exclusion criteria: patients taking additional prescribed eye drops for other eye conditions; patients diagnosed within the last 3 months; patients unable to self-administer eye drops 3. Intervention: Use of an in-office app that has both graphical and verbal (language-concordant) instruction for how to use drops. 4. Main outcome measure: Ability to correctly identify drops/regimen

Interventions

OTHERApp

App features (App will be used during the office visit): * Pictorial representation of drops (color-coded) and schedule. * Quiz to assess understanding of the regimen. * Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop. * Graphical print-out of the regimen.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with a diagnosis of glaucoma (any type) * drop regimen of at least 2 pressure-lowering drops * languages supported at this time: English, Spanish, Cantonese

Exclusion criteria

* concurrent eye conditions necessitating additional eye drops * inability to self-administer eye drops * inability to engage with app (either visual or other barrier)

Design outcomes

Primary

MeasureTime frameDescription
Percentage accuracy of drop regimen recall1 month follow up from time of interventionThis will be assessed through questions querying which drops the patients are taking, the number of times they are taking each drop, and the laterality of each drop. Each answer/drop will be individual recorded, and then total number of correct answers will be divided by the total number of questions.

Secondary

MeasureTime frameDescription
Overall medication adherence, assessed through the modified Morisky Adherence Scale, a widely published scale for general medication adherence1 month follow up from time of interventionAn 8 question survey (7 questions are yes/no, with the final question on a Likert scale) gauging overall medication adherence. Each question will be individually assessed (not summed into a cumulative score). The higher number of yes responses corresponds to a lower adherence score.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026